Metabolism and Pharmacokinetics of Oral Solution of [14C]-BI 201335 in Healthy Male Volunteers

NCT02182349 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 201335 NA soft gelatin capsule
DRUG: [14C]-BI 201335 NA radiolabelled drug

Sponsor

Boehringer Ingelheim